Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002561

Chief Medical Officer gave up 2,861 shares (to pay taxes)

  • Chief Medical Officer acquired 9,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rottinghaus Scott T. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-12 Grant or award : show line 1 in the form +9,750 27,668 D
2025-02-12 Shares withheld for taxes : show line 2 in the form −2,861 $5.59 $15,993 24,807 D
Loading xslF345X05/form4.xml…